Flavio Adsuara Cadegiani

Possui graduação em Medicina pela Universidade de Brasília (2008), com último ano realizado Internato Eletivo em Endocrinologia no St. Barts Hospital em Londres, Reino Unido, no período de maio a julho de 2008, com a Dra. Marta Korbonits. Realizou residência médica em Clínica Médica no Hospital Universitário de Brasília nos anos de 2009 e 2010, e durante 2 meses eletivo mais 1 mês de férias realizou Fellow em Síndrome da Fadiga Crônica e em Endocrinologia na University of Miami. Realizou residência médica em Endocrinologia e Metabologia no Hospital de Base do Distrito Federal nos anos de 2011 e 2012, com estágio eletivo de 2 meses na Unifesp/EPM. Em 2013 obteve o Título de Especialista em Endocrinologia e Metabolismo pela SBEM, mediante prova específica. De 2015 a 2016, realizou o mestrado na unidade de Adrenal e Hipertensão da disciplina de Endocrinologia Clínica da Unifesp/EPM com o Dr. Claudio Elias Kater, cujo título da dissertação foi "Adrenal Fatigue does not exist: a systematic review". Realizou o doutorado em 2017 até início de 2018, cuja defesa e aprovação deram-se no dia 23 de fevereiro de 2018, obtendo o título de doutor, também em Endocrinologia Clínica pela Universidade Federal de São Paulo, cuja pesquisa foi o estudo EROS (Endocrine and Metabolic Responses on Overtraining Syndrome).

Informações coletadas do Lattes em 17/09/2025

Acadêmico

Formação acadêmica

Doutorado em Medicina (Endocrinologia Clínica)

2016 - 2018

Universidade Federal de São Paulo
Título: PROJETO DE PESQUISA: ?AVALIAÇÃO DO EIXO HIPOTÁLAMO-HIPÓFISE-ADRENAL AO ESTRESSE EM PACIENTES COM OVERREACHING NÃO FUNCIONAL E SÍNDROME DE OVERTRAINING?
Cláudio Elias Kater. Palavras-chave: Adrenal; Overtraining; Overreaching.Grande área: Ciências da SaúdeGrande Área: Ciências da Saúde / Área: Medicina / Subárea: Adrenal. Grande Área: Ciências da Saúde / Área: Medicina / Subárea: Medicina do Esporte. Setores de atividade: Atividades de atenção à saúde humana.

Mestrado em Medicina (Endocrinologia Clínica)

2015 - 2017

Universidade Federal de São Paulo
Título: Adrenal Fatigue Does Not Exist: a Systematic Review., Ano de Obtenção: 2017
Cláudio Elias Kater.Palavras-chave: Adrenal Depletion; Adrenal Fatigue.Grande área: Ciências da SaúdeGrande Área: Ciências da Saúde / Área: Medicina / Subárea: Adrenal. Setores de atividade: Atividades de atenção à saúde humana.

Graduação em Medicina

2002 - 2008

Universidade de Brasília, UnB

Formação complementar

2014 - 2014

Pós-graduação. (Carga horária: 160h). , Associação Brasileira de Nutrologia, ABN, Brasil.

Idiomas

Inglês

Compreende Bem, Fala Bem, Lê Bem, Escreve Bem.

Espanhol

Compreende Bem, Fala Bem, Lê Bem, Escreve Bem.

Francês

Compreende Razoavelmente, Fala Bem, Lê Bem, Escreve Razoavelmente.

Áreas de atuação

Grande área: Ciências da Saúde / Área: Medicina / Subárea: Clínica Médica/Especialidade: Endocrinologia.

Grande área: Ciências da Saúde / Área: Medicina / Subárea: Adrenal.

Grande área: Ciências da Saúde / Área: Medicina / Subárea: Obesidade.

Grande área: Ciências da Saúde / Área: Medicina / Subárea: Diabetes.

Grande área: Ciências da Saúde / Área: Medicina / Subárea: Síndrome da Fadiga Crônica.

Produções bibliográficas

FALAVIGNA, MAICON BELLI, KARLYSE CLAUDINO BARBOSA, ALEXANDRE NAIME ZAVASCKI, ALEXANDRE PREHN NASTRI, ANA CATHARINA DE SEIXAS SANTOS SANTANA, CHRISTIANE MACHADO STEIN, CINARA GRÄF, DÉBORA DALMAS CADEGIANI, FLAVIO ADSUARA GUIMARÃES, HÉLIO PENNA MONTEIRO, JOSÉ TADEU FERREIRA, JULIANA CARVALHO DE AZEVEDO, LUCIANO CESAR PONTES MAGRI, MARCELO MIHAILENKO CHAVES SOBREIRA, MARCONE LIMA DIAS, MARIA BEATRIZ GANDRA DE SOUZA DE OLIVEIRA, MAURA SALAROLI CORRADI, MIRIAN DE FREITAS DAL BEN ROSA, REGIS HEINZELMANN, RICARDO SOUZA DA SILVA, ROSEMERI MAURICI JUNIOR, RUBENS BELFORT CIMERMAN, SERGIO COLPANI, VERÔNICA VEIGA, VIVIANE CORDEIRO , et al. DE CARVALHO, CARLOS ROBERTO RIBEIRO ; Brazilian guidelines for the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and Vascular Surgery (SBACV), Brazilian Society of Geriatrics and Gerontology (SBGG), Brazilian Society of Infectious Diseases (SBI), Brazilian Society of Fami. Brazilian Journal of Infectious Diseases , v. 26, p. 102347, 2022.
KORY, PIERRE ; MEDURI, GINFRANCO UMBERTO ; IGLESIAS, JOSE ; VARON, JOSEPH ; CADEGIANI, FLAVIO ADSUARA ; MARIK, PAUL E. . -MATH+- Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale. JOURNAL OF CLINICAL MEDICINE RESEARCH , v. 14, p. 53-79, 2022.
ZIMERMAN, RICARDO ARIEL ; FERRAREZE, PATRÍCIA ALINE GRÖHS ; CADEGIANI, FLAVIO ADSUARA ; WAMBIER, CARLOS GUSTAVO ; FONSECA, DANIEL DO NASCIMENTO ; DE SOUZA, ANDREA ROBERTO ; GOREN, ANDY ; ROTTA, LIANE NANCI ; REN, ZHIHUA ; THOMPSON, CLAUDIA ELIZABETH . Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil. FRONTIERS IN MEDICINE , v. 9, p. 806611, 2022.
KERR, LUCY ; CADEGIANI, FLAVIO A ; BALDI, FERNANDO ; LOBO, RAYSILDO B ; ASSAGRA, WASHINGTON LUIZ O ; PROENÇA, FERNANDO CARLOS ; KORY, PIERRE ; HIBBERD, JENNIFER A ; CHAMIE-QUINTERO, JUAN J . Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching. Cureus , v. 14, p. 21272, 2022.
CADEGIANI, FLAVIO A . Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings. Cureus , v. 14(8), p. e27883, 2022.
SANTOS, HEITOR O. ; CADEGIANI, FLÁVIO A. ; FORBES, SCOTT C. . Nonpharmacological Interventions for the Management of Testosterone and Sperm Parameters: A Scoping Review. CLINICAL THERAPEUTICS , v. 44, p. 1129-1149, 2022.
KERR, LUCY ; BALDI, FERNANDO ; LOBO, RAYSILDO ; ASSAGRA, WASHINGTON LUIZ ; PROENÇA, FERNANDO CARLOS ; CHAMIE, JUAN J ; HIBBERD, JENNIFER A ; KORY, PIERRE ; CADEGIANI, FLAVIO A . Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects. Cureus , v. 14(8), p. e28624, 2022.
DE JESUS SILVA, RAQUEL ; PINTO BORGES, LYSANDRO ; JOSÉ QUINTANS-JÚNIOR, LUCINDO ; FEREZIN RESENDE, CAMILA ; ADSUARA CADEGIANI, FLÁVIO ; HENRIQUE GOMES, JOÃO ; REBELLO MENDES, RENATA . Acute effects of a typical rhythmic gymnastic training session on physiological parameters in Olympic athletes. Kinesiology , v. 54, p. 278-287, 2022.
CADEGIANI, FLAVIO A ; ZIMERMAN, RICARDO A ; CAMPELLO DE SOUZA, BRUNO ; MCCOY, JOHN ; PEREIRA E COSTA, RUTE ALVES ; GUSTAVO WAMBIER, CARLOS ; GOREN, ANDY . The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort. Cureus , v. Jan, p. 1-10, 2021.
ZIMERMAN, RICARDO A ; CADEGIANI, FLAVIO A ; PEREIRA E COSTA, RUTE ALVES ; GOREN, ANDY ; CAMPELLO DE SOUZA, BRUNO . Stay-At-Home Orders Are Associated With Emergence of Novel SARS-CoV-2 Variants. Cureus , v. Mar, p. 13(3):e13819, 2021.
CADEGIANI, FLAVIO A ; MCCOY, JOHN ; GUSTAVO WAMBIER, CARLOS ; VAO-GALVÁN, SERGIO ; SHAPIRO, JERRY ; TOSTI, ANTONELLA ; ZIMERMAN, RICARDO A ; GOREN, ANDY . Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial. Cureus , v. Feb, p. 13(2):e13492, 2021.
CADEGIANI, FLAVIO A ; MCCOY, JOHN ; GUSTAVO WAMBIER, CARLOS ; GOREN, ANDY . Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial - Biochemical). Cureus , v. Feb, p. 13(2):e13047, 2021.
CADEGIANI, FLAVIO ; LIN, ERICA M ; GOREN, ANDY ; WAMBIER, CARLOS G . Potential risk for developing severe COVID-19 disease among anabolic steroid users. BMJ CASE REPORTS , v. 14, p. e241572, 2021.
NGUYEN, CRISTINA ; YALE, KATERINA ; GHIGI, ALESSANDRO ; ZHENG, KAI ; MESINKOVSKA, NATASHA ATANASKOVA ; WAMBIER, CARLOS GUSTAVO ; CADEGIANI, FLAVIO ADSUARA ; GOREN, ANDY . SARS-CoV-2 infection in patients with thyroid disease: a cross-sectional study. Annals of Thyroid , v. 6, p. 7-7, 2021.
CADEGIANI, FLAVIO A ; ZIMERMAN, RICARDO A ; FONSECA, DANIEL N ; CORREIA, MICHAEL N ; MULLER, MARCIO P ; BET, DIEGO LEONARDO ; SLAVIERO, MARCIO RAFAEL ; ZARDO, IVAN ; BENITES, PAULO ROBERTO ; BARROS, RENAN N ; PAULAIN, RAYSA W ; ONETY, DIRCE C ; ISRAEL, KARLA CRISTINA P ; GUSTAVO WAMBIER, CARLOS ; GOREN, ANDY . Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial. Cureus , v. 13, p. 20691, 2021.
ACKERMAN, KATHRYN E. ; COLLOMP, KATIA ; KATER, CLAUDIO E. ; CADEGIANI, FLAVIO ADSUARA . Editorial: New Perspectives on the Endocrinology of Physical Activity and Sport. Frontiers in Endocrinology , v. 12, p. 728756, 2021.
FRANCESCHI, VINÍCIUS BONETTI ; CALDANA, GABRIEL DICKIN ; PERIN, CHRISTIANO ; HORN, ALEXANDRE ; PETER, CAMILA ; CYBIS, GABRIELA BETTELLA ; FERRAREZE, PATRÍCIA ALINE GRÖHS ; ROTTA, LIANE NANCI ; CADEGIANI, FLÁVIO ADSUARA ; ZIMERMAN, RICARDO ARIEL ; THOMPSON, CLAUDIA ELIZABETH . Predominance of the SARS-CoV-2 Lineage P.1 and Its Sublineage P.1.2 in Patients from the Metropolitan Region of Porto Alegre, Southern Brazil in March 2021. PATHOGENS , v. 10, p. 988, 2021.
MCCOY, JOHN ; GOREN, ANDY ; CADEGIANI, FLÁVIO ADSUARA ; VAO-GALVÁN, SERGIO ; KOVACEVIC, MAJA ; SITUM, MIRNA ; SHAPIRO, JERRY ; SINCLAIR, RODNEY ; TOSTI, ANTONELLA ; STANIMIROVIC, ANDRIJA ; FONSECA, DANIEL ; DORNER, EDINETE ; ONETY, DIRCE COSTA ; ZIMERMAN, RICARDO ARIEL ; WAMBIER, CARLOS GUSTAVO . Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial. FRONTIERS IN MEDICINE , v. 8, p. 668698, 2021.
CADEGIANI, F.A. ; GOREN, A. ; WAMBIER, C.G. ; MCCOY, J. . Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients. New Microbes and New Infections , v. 43, p. 100915, 2021.
WAMBIER, CARLOS GUSTAVO ; MEHTA, NINA ; GOREN, ANDY ; CADEGIANI, FLAVIO A. . COVID-19, androgens, and androgenic alopecia. Dermatological Reviews , v. 2, p. 146-153, 2021.
CADEGIANI, FLAVIO ; ABRAO, TATIANA P C ; DA SILVA, PEDRO LUIZ H ; KATER, CLAUDIO E . MON-LB305 The -Normal- Hormonal Levels in Athletes: Should Reference Ranges Be Adapted for the Physically Active Population?. Journal of the Endocrine Society , v. 4, p. MON?LB305, 2020.
CADEGIANI, FLAVIO ; DA SILVA, PEDRO LUIZ H ; ABRAO, TATIANA P C ; KATER, CLAUDIO E . SAT-LB4 Novel Hormonal and Metabolic Markers of Recovery From Overtraining Syndrome Unveiled by the Longitudinal ARM of the Eros Study - the Eros-Longitudinal Study. Journal of the Endocrine Society , v. 4, p. SAT-LB4, 2020.
CADEGIANI, FLAVIO ; DA SILVA, PEDRO LUIZ H ; ABRAO, TATIANA P C ; KATER, CLAUDIO E . SAT-LB8 The Testosterone-To-Estradiol Ratio, Rather Than Testosterone or Estradiol Alone, Is a More Precise Marker of Metabolic-Related Outcomes in Males: Insights From a Systematic Review. Journal of the Endocrine Society , v. 4, p. SAT-LB8, 2020.
CADEGIANI, FLAVIO A ; DA SILVA, PEDRO LUIZ H . MON-LB311 Clinical Guidelines for the Research on the Endocrinology of Physical Activity and Sport. Journal of the Endocrine Society , v. 4, p. MON?LB311, 2020.
CADEGIANI, FLAVIO ; DA SILVA, PEDRO LUIZ H . MON-LB100 Novel Paradoxical Markers of Weight Loss: Is the Worse Actually the Better? a Retrospectiveanalysisof 1,567 Patientswith Obesity With Successful Clinical Weight-Loss Approaches. Journal of the Endocrine Society , v. 4, p. MON?LB100, 2020.
CADEGIANI, FLAVIO . MON-LB101 5-Year Data of an Aggressive Pharmacological Approach to Moderate and Morbid Obesity: Is Prevention of Bariatric Surgery Feasible in the Long Run?. Journal of the Endocrine Society , v. 4, p. MON?LB101, 2020.
CADEGIANI, FLÁVIO A. . Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM , v. 318, p. E587-E588, 2020.
CADEGIANI, FLAVIO ADSUARA ; DA SILVA, PEDRO HENRIQUE LUIZ ; ABRAO, TATIANA CAMARGO PEREIRA ; KATER, CLAUDIO ELIAS . Diagnosis of Overtraining Syndrome: Results of the Endocrine and Metabolic Responses on Overtraining Syndrome Study: EROS-DIAGNOSIS. JOURNAL OF SPORTS MEDICINE , v. 2020, p. 1-17, 2020.
GOREN, A. ; WAMBIER, C.G. ; HERRERA, S. ; MCCOY, J. ; VAO'GALVÁN, S. ; GIOIA, F. ; COMECHE, B. ; RON, R. ; SERRANO'VILLAR, S. ; RAMOS, P.M. ; CADEGIANI, F.A. ; KOVACEVIC, M. ; TOSTI, A. ; SHAPIRO, J. ; SINCLAIR, R. . Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , v. 1, p. e13-e15, 2020.
MCCOY, J. ; CADEGIANI, F.A. ; WAMBIER, C.G. ; HERRERA, S. ; VAO'GALVÁN, S. ; MESINKOVSKA, N.A. ; RAMOS, P.M. ; SHAPIRO, J. ; SINCLAIR, R. ; TOSTI, A. ; GOREN, A. . 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (ONLINE) , v. 4, p. e243-e246, 2020.
GOREN, ANDY ; CADEGIANI, FLAVIO ADSUARA ; WAMBIER, CARLOS GUSTAVO ; VANO-GALVAN, SERGIO ; TOSTI, ANTONELLA ; SHAPIRO, JERRY ; MESINKOVSKA, NATASHA ATANASKOVA ; RAMOS, PAULO MÜLLER ; SINCLAIR, RODNEY ; LUPI, OMAR ; HERCOGOVA, JANA ; MCCOY, JOHN . Androgenetic alopecia may be associated with weaker COVID-19T-cell immune response: An insight into a potential COVID-19 vaccine booster. MEDICAL HYPOTHESES , v. Jan, p. 110439, 2020.
MCCOY, J. ; WAMBIER, C.G. ; HERRERA, S. ; VAO'GALVÁN, S. ; GIOIA, F. ; COMECHE, B. ; RON, R. ; SERRANO'VILLAR, S. ; IWASIOW, R.M. ; TAYEB, M.A. ; CADEGIANI, F.A. ; MESINKOVSKA, N.A. ; SHAPIRO, J. ; SINCLAIR, R. ; GOREN, A. . Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (ONLINE) , v. 35, p. e15-e17, 2020.
CADEGIANI, F.A. ; LIM, R.K. ; GOREN, A. ; MCCOY, J. ; SITUM, M. ; KOVACEVIC, M. ; VAÓ GALVÁN, S. ; SINCLAIR, R. ; TOSTI, A. ; WAMBIER, C.G. . Clinical symptoms of hyperandrogenic women diagnosed with COVID-19. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (ONLINE) , v. 35, p. e101-e104, 2020.
CADEGIANI, FLAVIO A. ; SILVA, PEDRO HENRIQUE L. ; ABRAO, TATIANA C.P. ; KATER, CLAUDIO E. . Novel Markers of Recovery From Overtraining Syndrome: The EROS-LONGITUDINAL Study. International Journal of Sports Physiology and Performance , v. Jan, p. 1-10, 2020.
ANDERSON, TRAVIS ; WIDEMAN, LAURIE ; CADEGIANI, FLAVIO A. ; KATER, CLAUDIO E. . Effects of Overtraining Status on the Cortisol Awakening Response-Endocrine and Metabolic Responses on Overtraining Syndrome (EROS-CAR). International Journal of Sports Physiology and Performance , v. Mar, p. 1-9, 2020.
CADEGIANI, FLAVIO A. . Repurposing existing drugs for COVID-19: an endocrinology perspective. BMC Endocrine Disorders , v. 20, p. 149, 2020.
CADEGIANI, FLAVIO A. ; GOREN, ANDY ; WAMBIER, CARLOS G. . Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). MEDICAL HYPOTHESES , v. 143, p. 110112, 2020.
CADEGIANI, FLAVIO A. ; WAMBIER, CARLOS G. ; GOREN, ANDY . Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19. FRONTIERS IN MEDICINE , v. 7, p. 453, 2020.
CADEGIANI, FLAVIO A. ; KATER, CLAUDIO E. . Eating, Sleep, and Social Patterns as Independent Predictors of Clinical, Metabolic, and Biochemical Behaviors Among Elite Male Athletes: The EROS-PREDICTORS Study. Frontiers in Endocrinology , v. 11, p. 414, 2020.
CADEGIANI, F. A. ; KATER, C. E. . Basal Hormones and Biochemical Markers as Predictors of Overtraining Syndrome in Male Athletes: The EROS-BASAL Study. JOURNAL OF ATHLETIC TRAINING , v. 54, p. 906-914, 2019.
CADEGIANI, F. A. ; KATER, C. E. ; GAZOLA, MATHEUS . Clinical and biochemical characteristics of high-intensity functional training (HIFT) and overtraining syndrome: findings from the EROS study (The EROS-HIFT). JOURNAL OF SPORTS SCIENCES , v. 37, p. 1296-1307, 2019.
CADEGIANI, F. A. ; KATER, C. E. . Enhancement of hypothalamic-pituitary activity in male athletes: evidence of a novel hormonal mechanism of physical conditioning. BMC Endocrine Disorders , v. 19, p. 117, 2019.
CADEGIANI, F. A. ; KATER, C. E. . Novel causes and consequences of overtraining syndrome: the EROS-DISRUPTORS study. BMC Sports Science, Medicine and Rehabilitation , v. 11, p. 21, 2019.
CADEGIANI, FLAVIO A. ; KATER, CLAUDIO E. . Inter-correlations Among Clinical, Metabolic, and Biochemical Parameters and Their Predictive Value in Healthy and Overtrained Male Athletes: The EROS-CORRELATIONS Study. Frontiers in Endocrinology , v. 10, p. 858, 2019.
CADEGIANI, FLAVIO A. ; KATER, CLAUDIO E. . Body composition, metabolism, sleep, psychological and eating patterns of overtraining syndrome: Results of the EROS study (EROS-PROFILE). JOURNAL OF SPORTS SCIENCES , v. 1, p. 1-9, 2018.
CADEGIANI, F. A. ; KATER, C. E. . Hormonal conditioning: A new concept on athletic training. 33o Congresso Brasileiro de Endocrinologia e Metabologia (CBEM 2018). Arch Endocrinol Metab , v. 2018;62, p. S8, 2018.
CADEGIANI, F. A. ; KATER, C. E. . Defining the underlying features of overtraining syndrome: Deconditioning of optimized hormonal and metabolic responses in athletes.. Arch Endocrinol Metab , v. 2018;62, p. S110, 2018.
CADEGIANI, F. A. ; KATER, C. E. ; GAZOLA, M. . Clinical and biochemical characteristics of high-intensity functional training and overtraining syndrome with CrossFit: EROS-CROSSFIT, a post-hoc analysis of the Endocrine and metabolic Responses in Overtraining Syndrome (EROS) study.. Arch Endocrinol Metab , v. 2018;62, p. S109, 2018.
CADEGIANI, F. A. ; KATER, C. E. . Hypothalamic-pituitary-adrenal (HPA) axis functioning in overtraining syndrome: Findings from the Endocrine and metabolic Responses on Overtraining Syndrome (EROS) study ? EROS-HPA AXIS. Arch Endocrinol Metab , v. 2018;62, p. S111, 2018.
CADEGIANI, F. A. ; KATER, C. E. . Body composition, metabolism, sleep, psychological and eating patterns of overtraining syndrome: Results of the Endocrine and metabolic Responses on Overtraining Syndrome (EROS) study - (EROS-PROFILE).. Arch Endocrinol Metab , v. 2018;62, p. S9, 2018.
CADEGIANI, F. A. ; KATER, C. E. . Basal hormones and biochemical markers as predictors of overtraining syndrome: EROS-BASAL ? Results from the Endocrine and metabolic Responses on Overtraining Syndrome study. Arch Endocrinol Metab , v. 2018;62, p. S109, 2018.
CADEGIANI, FLAVIO A. ; DINIZ, GUSTAVO C. ; ALVES, GABRIELLA . Aggressive clinical approach to obesity improves metabolic and clinical outcomes and can prevent bariatric surgery: a single center experience. BMC Obesity , v. 4, p. 9, 2017.
CADEGIANI, FLAVIO A. ; KATER, CLAUDIO E. . Growth hormone (GH) and prolactin responses to a non-exercise stress test in athletes with overtraining syndrome: results from the Endocrine and metabolic Responses on Overtraining Syndrome (EROS) - EROS-STRESS. JOURNAL OF SCIENCE AND MEDICINE IN SPORT , v. 21, p. 648-653, 2017.
CADEGIANI, FLAVIO A. ; KATER, CLAUDIO E. . Hypothalamic-Pituitary-Adrenal (HPA) Axis Functioning in Overtraining Syndrome: Findings from Endocrine and Metabolic Responses on Overtraining Syndrome (EROS)-EROS-HPA Axis. SPORTS MEDICINE - OPEN (ONLINE) , v. 3, p. 45, 2017.
CADEGIANI, FLAVIO A. ; KATER, CLAUDIO E. . Hormonal aspects of overtraining syndrome: a systematic review. BMC Sports Science, Medicine and Rehabilitation , v. 9, p. 14, 2017.
CADEGIANI, F. A. . Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.. The American Journal of Case Reports , v. 17, p. 51-54, 2016.
CADEGIANI, FLAVIO A. ; KATER, CLAUDIO E. . Adrenal fatigue does not exist: a systematic review. BMC Endocrine Disorders , v. 16, p. 48, 2016.
CADEGIANI, FLAVIO . Overtraining Syndrome in Athletes. 1. ed. Springer International Publishing, 2020. v. 1. 333p .
CADEGIANI, FLAVIO A. . The Liver Before and After Bariatric Surgery. Dietary Interventions in Liver Disease. 1ed.: Elsevier, 2019, v. , p. 39-58.
CADEGIANI, F. A. . Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.. The American Journal of Case Reports , 2016.
CADEGIANI, F. A. . Pfizergate 2.0 - Active actions against competitive anti- COVID drugs? The case of the anti-androgens.. 2022. (Apresentação de Trabalho/Outra).
KERR, LUCY ; BALDI, FERNANDO ; LOBO, RAYSILDO B ; ASSAGRA, WASHINGTON LUIZ O ; PROENÇA, FERNANDO CARLOS ; HIBBERD, JENNIFER A ; CHAMIE-QUINTERO, JUAN J ; KORY, PIERRE ; CADEGIANI, F. A. . Strictly regular use of ivermectin as prophylaxis for COVID-19 leads to a 90% reduction in COVID-19 mortality rate, in a dose-response manner: definitive results of a prospective observational study of a strictly controlled 223,128 population from a city-wide program in Southern Brazil. 2022. (Apresentação de Trabalho/Outra).
CADEGIANI, F. A. . Catecholamines are the key trigger of mRNA SARS-CoV-2 and mRNA COVID-19 vaccine-induced myocarditis and sudden deaths: a compelling hypothesis supported by epidemiological, anatomopathological, molecular and physiological findings.. 2022. (Apresentação de Trabalho/Outra).
KERR, LUCY ; BALDI, FERNANDO ; LOBO, RAYSILDO B ; ASSAGRA, WASHINGTON LUIZ O ; PROENÇA, FERNANDO CARLOS ; HIBBERD, JENNIFER A ; CHAMIE-QUINTERO, JUAN J ; KORY, PIERRE ; CADEGIANI, F. A. . COVID-19 In-Hospital Mortality Rate is Reduced by Prophylactic Use of Ivermectin: Findings From a City-Wide, Prospective Observational Study Using Propensity Score Matching (PSM). 2021. (Apresentação de Trabalho/Outra).
CADEGIANI, F. A. ; ABRAO, T. C. P. ; SILVA, P. H. L. ; KATER, C. E. . The ?Normal? Hormonal Levels in Athletes: Should Reference Ranges Be Adapted for the Physically Active Population?. 2020. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; SILVA, P. H. L. ; ABRAO, T. C. P. ; KATER, CLAUDIO E. . Novel Hormonal and Metabolic Markers of Recovery From Overtraining Syndrome Unveiled by the Longitudinal ARM of the Eros Study - the Eros-Longitudinal Study. 2020. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; SILVA, P. H. L. ; ABRAO, T. C. P. ; KATER, C. E. . The Testosterone-To-Estradiol Ratio, Rather Than Testosterone or Estradiol Alone, Is a More Precise Marker of Metabolic-Related Outcomes in Males: Insights From a Systematic Review. 2020. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; SILVA, P. H. L. . Novel Paradoxical Markers of Weight Loss: Is the Worse Actually the Better? a Retrospective analysis of 1,567 Patients with Obesity and Successful Clinical Weight-Loss Approaches. 2020. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . 5-Year Data of an Aggressive Pharmacological Approach to Moderate and Morbid Obesity: Is Prevention of Bariatric Surgery Feasible in the Long Run?. 2020. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Growth Hormone (GH) and prolactin responses to a non-exercise stress test in healthy athletes and in athletes with overtraining syndrome: results from the Endocrine and metabolic Responses on Overtraining Syndrome (EROS) - EROS-STRESS. 2020. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Body composition, metabolism, sleep, psychological and eating patterns in healthy athletes and in overtraining syndrome: results of the Endocrine and metabolic Responses in Overtraining Syndrome (EROS) study (EROS-PROFILE). 2020. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Hypothalamic-pituitary-adrenal (HPA) axis functioning in healthy athletes and in overtraining syndrome: findings from Endocrine and Metabolic Responses on Overtraining Syndrome (EROS) - EROS-HPA axis. 2018. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Basal hormones and biochemical markers as predictors of overtraining syndrome: results from the Endocrine and metabolic Responses on Overtraining Syndrome (EROS) study ? EROS-BASAL. 2018. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Hormonal conditioning: a new concept on athletic training. 2018. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Defining the underlying features of overtraining syndrome: deconditioning of optimized hormonal and metabolic responses in athletes. 2018. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Hormonal conditioning: A new concept on athletic training.. 2018. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Defining the underlying features of overtraining syndrome: Deconditioning of optimized hormonal and metabolic responses in athletes. 2018. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. ; GAZOLA, M. . Clinical and biochemical characteristics of high-intensity functional training and overtraining syndrome with CrossFit: EROS-CROSSFIT, a post-hoc analysis of the Endocrine and metabolic Responses in Overtraining Syndrome (EROS) study. 2018. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Hypothalamic-pituitary-adrenal (HPA) axis functioning in overtraining syndrome: Findings from the Endocrine and metabolic Responses on Overtraining Syndrome (EROS) study ? EROS-HPA AXIS. 2018. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Body composition, metabolism, sleep, psychological and eating patterns of overtraining syndrome: Results of the Endocrine and metabolic Responses on Overtraining Syndrome (EROS) study - (EROS-PROFILE). 2018. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Basal hormones and biochemical markers as predictors of overtraining syndrome: EROS-BASAL ? Results from the Endocrine and metabolic Responses on Overtraining Syndrome study. 2018. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Adrenal Fatigue: Myth or Reality? a Systematic Review.. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; KATER, C. E. . Hormonal Aspects in Overtraining Syndrome: A Systematic Review.. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Non Alcoholic Steatohepatitis (NASH) Resolution with Obesity Therapy: Should Obesity be Treated Prior to Specific Nash Treatment in All Obese Patients?. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Weight Loss Among Hormonally Compensated Hypothyroidism Obese Patients Unresponsive to Obesity Therapy after Addition of Liothyronine (T3). May T3 be Helpful in Selected Patients?. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Use of Liothyronine in Hormonally Compensated but Clinically Persistent Hypothyroidism: A Matter of Patient Selection?. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; DINIZ, G. C. ; ALVES, G. F. P. C. ; MACEDO, G. B. . T2DM, NASH, Hypertension, Hypertriglyceridemia, Metabolic Syndrome And Morbid Obesity, A Harmful Sextuple : Complete Remission Of Multiple Disorders By Clinical Intervention Against Obesity.. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Low Dose Of Anabolic Steroid (AS) Oxandrolone For Sarcopenic Post-bariatric Patients Can Be Safe And Effective.. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Anabolic Steroid (AS) Nandrolone In Sarcopenic Post-bariatric Patients: Does It Improve Appearance, Protein Absorption And Synthesis And Muscle Mass?. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Effects Of GLP-1 Analogue As An Add-on Therapy On Obesity Therapy: Does It Enhance Results?. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Effects Of SGLT-2 Inhibitors As An Add-on Therapy On Obesity Therapy With GLP-1 Analogues: Does It Help Improve Outcomes?. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; SILVA, O. S. . SGLT-2 Inhibitors (SGLT2i) As Monotherapy Against Obesity: Is It Feasible?. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Metabolic Outcomes Of Association Of GLP-1 And SGLT-2 In Obese Pre-diabetic Patients. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Slow Interruption Of Drugs Against Obesity Can Be An Effective Method To Prevent Obesity Relapse.. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . GLP-1 Analogue (GLP1a) And SGLT-2 Inhibitor (SGLT2i) Double Therapy In Patients Unresponsive To Current On-label Therapy Against Obesity: A Powerful And Effective Association.. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Psychotherapy In Obesity Intervention: Does It Matter?. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Acarbose Can Promote Complete Remission Of Both Early And Late Dumping Syndromes And Increase Exercise Capacity In Post-bariatric Patients.. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; DINIZ, G. C. . A Different Protocol Using Liraglutide For Obesity Can Be As Efficient, Promote Less Symptoms And Withdraw And Be Less Expensive Than Standardized Protocol.. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; SILVA, O. S. . Effects Of Double Introduction Of GLP-1 Analogue (GLP1a) And SGLT-2 Inhibitor (SGLT2i) In Diabetic Obese Patients Already Under Therapy Against T2DM: A Promising Future?. 2016. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Obesidade, Hormônios e Outros Mitos. 2016. (Apresentação de Trabalho/Conferência ou palestra).
CADEGIANI, F. A. . Por quê você é gordo?. 2016. (Apresentação de Trabalho/Conferência ou palestra).
CADEGIANI, F. A. . Bridging Endocrinology & Anti-Aging Medicine: What?s Right?. 2016. (Apresentação de Trabalho/Simpósio).
CADEGIANI, F. A. . Mastermind Session: How To Make Functional Medicine Successful In Your Community.. 2016. (Apresentação de Trabalho/Simpósio).
CADEGIANI, F. A. ; CADEGIANI, F. A. . Short-term follow up of ?Gold Standard Body Analysis Surveillance? protocol: The role of surveillance in the efficacy of obesity intervention.. 2015. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . A continuous surveillance and follow-up can perpetuate weight loss after discontinuing drugs for obesity.. 2015. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . A new approach to the obese patient: An intensive and comprehensive therapy joining different modalities can bring significant results.. 2015. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . An aggressive clinical approach may prevent bariatric surgery.. 2015. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; DINIZ, G. C. . Metabolic outcomes of an intensive lifestyle, behavioral and pharmacological intervention protocol for preventing bariatric surgery.. 2015. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; DINIZ, G. C. ; ALVES, G. F. P. C. . Metabolic syndrome and obesity resolution as a result of an intensive multimodal obesity intervention protocol.. 2015. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. ; MACEDO, G. B. . A quadruple anti-diabetic association may present significant results in patients unresponsive to diet and exercise.. 2015. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . A powerful probiotic can improve fat weight loss in refractory patients.. 2015. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . A review over evaluation methods of response to obesity therapies ? Are scientific and medical communities too ?weight-centered'?. 2015. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Indications for bariatric surgery ? Are some doctors going too far?. 2015. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Saúde, Alimentação, Beleza e Estética.. 2015. (Apresentação de Trabalho/Conferência ou palestra).
CADEGIANI, F. A. . Por quê você é gordo?. 2015. (Apresentação de Trabalho/Conferência ou palestra).
CADEGIANI, F. A. . Por quê você é gordo?. 2015. (Apresentação de Trabalho/Conferência ou palestra).
CADEGIANI, F. A. . Bridging Endocrinology & Anti-Aging Medicine: What is right?. 2015. (Apresentação de Trabalho/Simpósio).
CADEGIANI, F. A. . Testosterone: the real indications, beyond Endocrinology, being safe.. 2015. (Apresentação de Trabalho/Simpósio).
CADEGIANI, F. A. . Menopause - the truth, myth, wellness, safety, & the final answer.. 2015. (Apresentação de Trabalho/Simpósio).
CADEGIANI, F. A. . Mastermind session: Endocrinology, Hormones and safety - what you need to know.. 2015. (Apresentação de Trabalho/Simpósio).
CADEGIANI, F. A. . Hormonophobia: Impartial view over endocrine treatments and hormone balance.. 2015. (Apresentação de Trabalho/Congresso).
CADEGIANI, F. A. . Adrenal Depletion: From an Endocrinologist Perspective.. 2015. (Apresentação de Trabalho/Congresso).

Outras produções

CADEGIANI, F. A. . Regenerative Business Summit 2nd Edition. 2016. (Curso de curta duração ministrado/Especialização).

CADEGIANI, F. A. . Regenerative Business Summit 1st Edition. 2015. (Curso de curta duração ministrado/Especialização).

Prêmios

2013

Título de Especialista em Endocrinologia e Metabologia, Sociedade Brasileira de Endocrinologia e Metabologia (SBEM).

Histórico profissional

Experiência profissional

2013 - Atual

Corpometria

Vínculo: Diretor Médico, Enquadramento Funcional: CEO, Carga horária: 40

Outras informações:
Centro privado de tratamento de obesidade e outras doenças endocrinológicas.

2013 - 2018

Universidade Federal de São Paulo

Vínculo: Pós-Graduando, Enquadramento Funcional: Mestrando/Doutorando, Carga horária: 40

Outras informações:
Formalmente, vínculo terminado em março de 2018. Informalmente segui orientando alunos de mestrado e doutorado até o início de 2020.

2021 - Atual

Applied Biology Inc.

Vínculo: Celetista, Enquadramento Funcional: Diretor Clínico, Carga horária: 20